Neural Mechanisms Underlying the Antidepressant Effects of Sleep Deprivation
1 other identifier
interventional
50
1 country
1
Brief Summary
From 40 to 60% of patients with depression experience a rapid and significant improvement of mood with one night of sleep deprivation (SD). The neural mechanisms underlying this effect have not been elucidated. Recent advances in functional neuroimaging have provided new opportunities to investigate state changes in regional brain function, along with a better understanding of the neural networks affected by depression and SD. Here we propose to study a group of N=48 antidepressant-free male and female patients with current depression symptom and N=12 healthy controls with no history of mood disorders before and after SD to provide mechanistic insight into the neural substrates underlying the antidepressant effects of SD. We hypothesize that SD-induced concurrent functional activity and connectivity changes in multiple brain networks related to different depressive symptom dimensions including emotion regulation, attention, arousal, self-referential, and reward processing will underlie the rapid and transient antidepressant effects of SD. Using an ABA design, multimodal brain imaging along with more traditional electroencephalographic (EEG) and neurobehavioral testing data will be acquired at baseline after normal sleep, during one night of total SD, and after one night of recovery sleep using a 5-day in laboratory protocol during which subjects will be continuously monitored by trained staff.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
May 24, 2017
CompletedFirst Posted
Study publicly available on registry
May 30, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2020
CompletedMarch 25, 2020
March 1, 2020
3.9 years
May 24, 2017
March 24, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in HAMD-NOW scores
Total score on a modified Hamilton Depression Inventory that assesses mood symptoms in the moment.
Each morning for 4 days
Secondary Outcomes (1)
Change in neuroimaging
Each morning for 3 days
Study Arms (1)
Sleep deprivation
EXPERIMENTAL36-hours of total sleep deprivation
Interventions
Eligibility Criteria
You may qualify if:
- Current depression as assessed on the HDRS-17 (for depressed group only)
- Body mass index within 15% of normal
- Stable, normally-timed sleep-wake cycle defined by: a. Habitual nocturnal sleep duration between 6h and 9h. b. Habitual morning awakening between 0600h and 0800h.
- Able to comprehend English, as all questionnaires are in this language
- Ability to provide informed consent
You may not qualify if:
- Shift work, transmeridian travel or irregular sleep/wake routine in past 60 days
- A sleep disorder other than insomnia
- History of bipolar disorder, delirium, dementia, amnestic disorder, schizophrenia and other psychotic disorders
- No history of depression for the control group.
- Alcohol or drug abuse in the past year
- A current smoker.
- Any acute or chronic, debilitating medical conditions, epilepsy, or thyroid disease.
- Metallic implants, pacemakers or tattoos, or history of working in metal workshops.
- Claustrophobic, or intolerant of the scanner environment.
- For women, pregnancy will exclude participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Philip Gehrman, PhD
University of Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2017
First Posted
May 30, 2017
Study Start
April 1, 2016
Primary Completion
February 28, 2020
Study Completion
February 28, 2020
Last Updated
March 25, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share